Results 251 to 260 of about 10,534,234 (296)
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Clinical Laboratory, 2017
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo, Moriyama, Eiko, Takahashi
openaire +2 more sources
Malondialdehyde low-density lipoprotein (MDA-LDL) is a major form of oxidized LDL and considered to be more atherogenic than LDL. Information on major determinants of MDA-LDL and their association in subjects who are not under treatment for diabetes mellitus and dyslipidemia is limited.This study included 778 Japanese subjects who were not taking ...
Kengo, Moriyama, Eiko, Takahashi
openaire +2 more sources
Cyclosporine, Low-Density Lipoprotein, and Cholesterol
Mayo Clinic Proceedings, 1988Lipoproteins are known to be able to transport a variety of drugs. This report suggests that low-density lipoprotein not only functions as an important carrier of cyclosporine in plasma but also facilitates transport of cyclosporine across the cell membrane by means of the low-density lipoprotein receptor. Such a mechanism would explain (1) the similar
openaire +2 more sources
Low-Density Lipoprotein Cholesterol in Subclinical Hypothyroidism
Thyroid, 2000The significance of subclinical hypothyroidism in regard to ensuing hyperlipidemia remains unclear. Because an unfavorable lipid profile would provide a possible explanation for the reported association of coronary-heart disease with this syndrome, we have evaluated the relationship of thyrotropin (TSH) with total cholesterol, low-density-lipoprotein ...
H, Vierhapper +4 more
openaire +2 more sources
Reaching low density lipoprotein cholesterol targets
Current Medical Research and Opinion, 2014Cardiovascular disease is a major health problem and within the leading causes of death worldwide. Low-density lipoprotein cholesterol (LDL-C) is strongly associated with the development and progression of cardiovascular disease and is among the main targets of lipid lowering therapy.
Christos V, Rizos +2 more
openaire +2 more sources
“Isolated” Low High-Density Lipoprotein Cholesterol
Annals of Pharmacotherapy, 1997OBJECTIVE: To present information on the function, structure, and importance of high-density lipoprotein cholesterol (HDL-C) and to evaluate the current literature regarding the controversy of managing patients with an “isolated” low HDL-C concentration ...
V M, Wilt, J G, Gums
openaire +2 more sources
Reliability of Calculated Low-Density Lipoprotein Cholesterol
The American Journal of Cardiology, 2015Aggressive low-density lipoprotein cholesterol (LDL-C)-lowering strategies are recommended for prevention of cardiovascular events in high-risk populations. Guidelines recommend a 30% to 50% reduction in at-risk patients even when LDL-C concentrations are between 70 and 130 mg/dl (1.8 to 3.4 mmol/L).
Jeffrey W, Meeusen +4 more
openaire +2 more sources
Direct testing for low-density lipoprotein cholesterol
The American Journal of Cardiology, 19956. Ismen S. Olsen K, Jacohscn E. IGclscn H, S&en A. Pietensen A. Jensen 0. Pedenen I-‘, Waahcn J. Kehlet H. Hansen J. Dalgaard P. Nyboe J. Predictmu of cardiac risk in non-cardiac surgery. Lur f&w? J I9R7:8:179 18.5. 7. Ashmn C, Pewson Ii. Wray N, Kiefe C. Dunn J. Wu 1.. Thomas J.
openaire +2 more sources
Update on low-density lipoprotein cholesterol quantification
Current Opinion in Lipidology, 2019Purpose of review β-Quantification is considered the reference measurement procedure for low-density lipoprotein cholesterol (LDL-C). However, this technique is time-consuming and thus is inappropriate for routine clinical practice. Therefore, the Friedewald equation or homogeneous assays have been widely utilized.
openaire +2 more sources

